ArticleRadiation and environmental biophysics2026
Leukaemia and lymphoma radiation risk models from atomic bomb survivors (1950-2001) suitable for lifetime risk calculations.
Article in Radiation and environmental biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper updates radiation risk models for leukaemia and lymphoma incidence that can be applied to a variety of adult exposure scenarios and ages of onset of leukaemia and lymphoma, derived from the Life Span Study of atomic bomb survivors of Hiroshima and Nagasaki. Models were developed for four groups of haematological malignancies: acute lymphoblastic leukaemia (ALL), acute myeloblastic leukaemia (AML), chronic myeloid leukaemia (CML), and Hodgkin and non-Hodgkin lymphoma (LYM). Multi-model inference methodology was applied for all groups to construct flexible radiation risk models. The models revealed complex radiation risk patterns with strong dependencies on dose, age, and sex. The ALL group showed high radio-sensitivity with risk decreasing strongly with attained age. The AML group demonstrated a strong non-linear dose response requiring special considerations for fractionated or protracted exposures. The CML model showed a strong dependence on time since exposure. Excess relative risk for the lymphoma group was smaller than other groups and displayed significant sex differences. The developed models for leukaemia and lymphoma provide robust risk predictions for a large variety of adult exposure scenarios with ionising radiation. Multi-model inference proved to be an important tool in the construction of such flexible risk models. The models can be safely used in risk assessment tools or for lifetime risk evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.